Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | LA |
Respiratory problems; This is a spontaneous report received from a Consumer or other non HCP. A 64-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 30Oct2025 at 16:00 as dose 1, single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 30Oct2025 as dose number unknown, single, in left arm for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: RESPIRATORY DISORDER (non-serious) with onset 03Nov2025 at 05:00, outcome "not recovered", described as "Respiratory problems". Therapeutic measures were taken as a result of respiratory disorder. Additional information: No Known Allergy. The patient did not received any other vaccines within 4 weeks Prior to the vaccine. The patient was not taking any other medications within 2 weeks of the event starting. Treatment received for the adverse event included Amoxicillin, steroids and pearls. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: No Medical history